237 related articles for article (PubMed ID: 2881040)
1. Haemolytic transfusion reactions due to HLA antibodies. A prospective study combining red-cell serology with investigations of chromium-51-labelled red-cell kinetics.
Panzer S; Püchler K; Mayr WR; Höcker P; Graninger W; Lechner K
Lancet; 1987 Feb; 1(8531):474-8. PubMed ID: 2881040
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of HLA antigens on red cells. Survival studies in HLA-sensitized individuals.
Panzer S; Mueller-Eckhardt G; Salama A; Strauss BE; Kiefel V; Mueller-Eckhardt C
Transfusion; 1984; 24(6):486-9. PubMed ID: 6542262
[TBL] [Abstract][Full Text] [Related]
3. Acute and delayed hemolytic transfusion reactions secondary to HLA alloimmunization.
Benson K; Agosti SJ; Latoni-Benedetti GE; Leparc GF
Transfusion; 2003 Jun; 43(6):753-7. PubMed ID: 12757526
[TBL] [Abstract][Full Text] [Related]
4. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
Takeuchi C; Ohto H; Miura S; Yasuda H; Ono S; Ogata T
Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
[TBL] [Abstract][Full Text] [Related]
5. Do HLA antibodies cause hemolytic transfusion reactions or decreased RBC survival?
Nance ST
Transfusion; 2003 Jun; 43(6):687-90. PubMed ID: 12757516
[No Abstract] [Full Text] [Related]
6. Platelet transfusion reaction associated with interdonor HLA incompatibility.
Eastlund DT; McGrath PC; Burkart P
Vox Sang; 1988; 55(3):157-60. PubMed ID: 3266389
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.
Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM
Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842
[TBL] [Abstract][Full Text] [Related]
8. Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion.
Weinstock C; Möhle R; Dorn C; Weisel K; Höchsmann B; Schrezenmeier H; Kanz L
Transfusion; 2015 Mar; 55(3):605-10. PubMed ID: 25251967
[TBL] [Abstract][Full Text] [Related]
9. [Immunohematologic study and transfusion approach to patients with public antibodies].
Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms responsible for delayed and immediate hemolytic transfusion reactions in a patient with anti-E + Jk(b)+ Di(b) and anti-HLA alloantibodies.
Okamoto T; Hashimoto M; Samejima H; Mori A; Wakabayashi M; Takeda A; Nakamura H; Naruse H; Bouike Y; Araki N
Immunopharmacol Immunotoxicol; 2004; 26(4):645-52. PubMed ID: 15658612
[TBL] [Abstract][Full Text] [Related]
11. The James Blundell Award Lecture 2007: do we really understand immune red cell destruction?
Garratty G
Transfus Med; 2008 Dec; 18(6):321-34. PubMed ID: 19140815
[TBL] [Abstract][Full Text] [Related]
12. Haemolytic transfusion reactions caused by non-ABO red cell antibodies reported to the Norwegian Haemovigilance System 2004-2020.
Espinosa A; Steinsvåg CT; Flesland Ø
Vox Sang; 2024 May; 119(5):483-489. PubMed ID: 38373854
[TBL] [Abstract][Full Text] [Related]
13. Hemolytic transfusion reactions in a dog with an alloantibody to a common antigen.
Callan MB; Jones LT; Giger U
J Vet Intern Med; 1995; 9(4):277-9. PubMed ID: 8523326
[TBL] [Abstract][Full Text] [Related]
14. Haemolytic transfusion reaction due to anti-Sda.
Peetermans ME; Cole-Dergent J
Vox Sang; 1970 Jan; 18(1):67-70. PubMed ID: 5417349
[No Abstract] [Full Text] [Related]
15. Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo.
Silliman CC; Kelher MR; Khan SY; LaSarre M; West FB; Land KJ; Mish B; Ceriano L; Sowemimo-Coker S
Blood; 2014 May; 123(22):3488-95. PubMed ID: 24747436
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias.
Thedsawad A; Taka O; Wanachiwanawin W
Hematology; 2019 Dec; 24(1):208-214. PubMed ID: 30479186
[TBL] [Abstract][Full Text] [Related]
17. [Significance of blood transfusion in the development of cytotoxic antibodies in patients on hemodialysis].
Stanković B; Taseski J; Balint B; Trkuljić M; Veljancić V; Hrvacević R; Marić M; Stolić I; Andrić Z
Vojnosanit Pregl; 2000; 57(5):37-41. PubMed ID: 11213673
[TBL] [Abstract][Full Text] [Related]
18. A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation.
Girard-Pierce KR; Stowell SR; Smith NH; Arthur CM; Sullivan HC; Hendrickson JE; Zimring JC
Blood; 2013 Sep; 122(10):1793-801. PubMed ID: 23878139
[TBL] [Abstract][Full Text] [Related]
19. HLA antigens on red cells. Implications for achieving low HLA antigen content in blood transfusions.
Rivera R; Scornik JC
Transfusion; 1986; 26(4):375-81. PubMed ID: 3523874
[TBL] [Abstract][Full Text] [Related]
20. Survival Time of Cross-Match Incompatible Red Blood Cells in Adult Horses.
Tomlinson JE; Taberner E; Boston RC; Owens SD; Nolen-Walston RD
J Vet Intern Med; 2015; 29(6):1683-8. PubMed ID: 26478135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
